U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C48H75NO17
Molecular Weight 938.1056
Optical Activity UNSPECIFIED
Defined Stereocenters 19 / 19
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AMPHOTERICIN B METHYL ESTER

SMILES

[H][C@]12C[C@@H](O[C@]3([H])O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(=O)OC)O2

InChI

InChIKey=UAZIZEMIKKIBCA-TYVGYKFWSA-N
InChI=1S/C48H75NO17/c1-28-18-16-14-12-10-8-6-7-9-11-13-15-17-19-35(65-47-45(59)42(49)44(58)31(4)64-47)25-39-41(46(60)62-5)38(55)27-48(61,66-39)26-34(52)23-37(54)36(53)21-20-32(50)22-33(51)24-40(56)63-30(3)29(2)43(28)57/h6-19,28-39,41-45,47,50-55,57-59,61H,20-27,49H2,1-5H3/b7-6+,10-8+,11-9+,14-12+,15-13+,18-16+,19-17+/t28-,29-,30-,31+,32+,33+,34-,35-,36+,37+,38-,39-,41+,42-,43+,44+,45-,47-,48+/m0/s1

HIDE SMILES / InChI
Amphotericin B methyl ester (also known as metamphocin), a more soluble and less toxic formulation of amphotericin B, is a new antifungal polyene antibiotic, which was studied to treat ocular mycoses and was proposed to treat Candida endophthalmitis. The suggested mechanism of its action includes the binding of this drug with the ergosterol-containing membranes.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Unknown

Approved Use

Unknown
Curative
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Inhibition of human immunodeficiency virus type 1 assembly and release by the cholesterol-binding compound amphotericin B methyl ester: evidence for Vpu dependence.
2008 Oct
Comparative in vitro antifungal susceptibility activity of amphotericin B versus amphotericin B methyl ester against Candida albicans ocular isolates.
2012 Dec
Patents

Sample Use Guides

8 patients with keratomycosis and 2 patients with fungal endophthalmitis: drop-like intravenous injections
Route of Administration: Intravenous
The in vitro susceptibility of amphotericin B methyl ester (AME) was determined for C. albicans isolates recovered from endophthalmitis (N=10) and for C. albicans ATCC reference strain 90028 using the Clinical and Laboratory Standards Institute M27-A2 (NCCLS/CLSI) broth dilution method. All isolates were obtained from samples of vitreous humor of patients with suspected endophthalmitis within the last 5 years at the Bascom Palmer Eye Institute, University of Miami Miller School of Medicine (Miami, FL). The minimal inhibitory concentrations (MICs) of AME was (0.125-1 μg/mL). The MIC(90) was equal (1 μg/mL). The minimal fungicidal concentrations (MFCs) of AME was (0.125-2 μg/mL).
Name Type Language
AMPHOTERICIN B METHYL ESTER
Common Name English
AME
Common Name English
Code System Code Type Description
CAS
36148-89-7
Created by admin on Fri Dec 15 15:25:23 GMT 2023 , Edited by admin on Fri Dec 15 15:25:23 GMT 2023
PRIMARY
MESH
C017501
Created by admin on Fri Dec 15 15:25:23 GMT 2023 , Edited by admin on Fri Dec 15 15:25:23 GMT 2023
PRIMARY
PUBCHEM
11968030
Created by admin on Fri Dec 15 15:25:23 GMT 2023 , Edited by admin on Fri Dec 15 15:25:23 GMT 2023
PRIMARY
EPA CompTox
DTXSID701009331
Created by admin on Fri Dec 15 15:25:23 GMT 2023 , Edited by admin on Fri Dec 15 15:25:23 GMT 2023
PRIMARY
FDA UNII
074Z98YIW3
Created by admin on Fri Dec 15 15:25:23 GMT 2023 , Edited by admin on Fri Dec 15 15:25:23 GMT 2023
PRIMARY